- Congresos
- IMCAS Americas - abril 2025
- IMCAS Asia - junio 2025
- IMCAS China - julio 2025
- IMCAS World Congress - enero 2026
- Masterclases
- IMCAS India - noviembre 2025
- Congresos
- IMCAS Americas - abril 2025
- IMCAS Asia - junio 2025
- IMCAS China - julio 2025
- IMCAS World Congress - enero 2026
- Masterclases
- IMCAS India - noviembre 2025

IMCAS Academy

Presentación
Programa
Oradores
Listado de sponsors
Mapa del congreso
Acreditación

VOLVER

World Congress 2020
Programa

S135

PBSerum Medical Symposium - PBSerum biotechnological enzymes, at the forefront of non-invasive therapies for tissue regeneration and volume remodelling

Sala: Room 143 - level 1
Fecha: viernes 31 enero 2020 de 16:30 a 17:30
Formato: SIMPOSIO DE LA INDUSTRIA > Programa educativo y promocional realizado por la empresa patrocinadora

Las presentaciones

Horas	Oradores	Título de la presentación	Resumen	Número
16:30	Dr Sara CARDENOSO GIGOSOS	PBSerum recombinant enzymes and HMWHA combined mechanism of action in cutaneous and subcutaneous tissues: “degrading to create”	Ver	98575
16:45	Dr Elena RUMYANTSEVA MATHEY	Opinion Leader, specialist in dermatology, dermatological surgery and aesthetic medicine:New enzymatic therapy for integral facial remodelling and intensive neck lifting. The importance of diagnose and application technique	Ver	99643

Ver sesiones anteriores

Ver la siguiente sesión

Dr Sara CARDENOSO GIGOSOS

Farmacólogo

España

Otro(s) autor(es) :

PBSerum recombinant enzymes and HMWHA combined mechanism of action in cutaneous and subcutaneous tissues: “degrading to create”

Objectives: Understand the mechanism of action of each one of the PBSerum recombinant enzymes and their synergic effect when applied together along with HMWHA in cutaneous and subcutaneous tissues.

Introduction: The use of recombinant enzymes along with HMWHA in the treatment of diverse skin problems is generating an increasingly significant interest thanks to their differential advantages over other molecules. While HMWA has proven efficacy in the prevention and treatment of fibrosis, enzymes are very selective molecules that catalyze metabolic reactions, being specific for a substrate on which they act without damaging adjacent structures. This specificity reduces the possibility of having any complication or adverse effect and it is responsible for their high security and efficacy level.

Materials / method: - PBSerum recombinant enzymes (collagenase, lipase, lyase)
- High Molecular Weight Hyaluronic Acid

Results: HMWHA decreases the rate of the fibrosis in affected tissues, playing a key role in its prevention and treatment.

Recombinant enzymes have proven efficacy in the treatment of diverse skin pathologies: fat accumulation, cellulite, flaccidity, scars, fibrosis… The clinical practice has revealed that they degrade specifically the substrates that mainly cause them (collagenase removes atrophic collagen fibers that lead to flaccidity and fibrosis, lipase degrades TG inside the adipocyte reducing fat accumulation and lyase acts in synergy with the other enzymes as a vehicle to help their expansion)

Conclusion: The combination of PBSerum recombinant enzymes with HMWHA have shown very favorable and encouraging results that may change the approach in the way certain skin pathologies have been treated so far.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.

Dr Elena RUMYANTSEVA MATHEY

Dermatólogo

Francia

Otro(s) autor(es) :

Opinion Leader, specialist in dermatology, dermatological surgery and aesthetic medicine:New enzymatic therapy for integral facial remodelling and intensive neck lifting. The importance of diagnose and application technique

Objectives: Highlight the importance of doing a right diagnose and choosing the appropriate application techniques when using recombinant enzymes and HMWHA to perform an integral remodeling of the face and neck.

Introduction: The use of recombinant enzymes along with HMWHA provides a 360º approach to the treatment of localized fat, flaccidity and aging signs in both face and neck with proven efficacy and minimal risk of adverse effects. They will degrade specific substrates in the skin and subcutaneous tissues, acting directly on the origin of problem. Due to this specificity, the election of a correct application technique is essential to obtaining the best results possible.

Materials / method: - PBSerum recombinant enzymes (collagenase, lipase, lyase)
- High Molecular Weight Hyaluronic Acid
- Anesthetic cream & Simple lidocaine 2%
- Needles (30Gx1/2), Cannula- Gauzes, Antiseptic solution

Results: After the application of HMWHA along with collagenase, lipase and lyase with the appropriate technique in the face and neck we can observe a global remodeling of the skin’s collagen matrix, a reduction of the excess subcutaneous fat accumulations and an improvement on skin’s elasticity and texture. Both the diagnose and the application protocol performed in each particular case play a key role in the final results obtained.

Conclusion: The combination of PBSerum recombinant enzymes with HMWHA has proven efficacy in the reduction of localized fat, flaccidity and aging signs in both face and neck. With the correct diagnose and the election of the appropriate application techniques, this non-invasive and highly effective treatment will provide visible and long-lasting results in a wide range of cases.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.

¿Tiene una pregunta?

Encuentre las respuestas rápidamente en nuestra sección de FAQ.

Congresos

IMCAS Americas
IMCAS Asia
IMCAS China
IMCAS World Congress

Acerca de

Empresa
Política de Confidencialidad
Mención legal

Academy

Inicio
Cursos
Webinars
Explorar
Blog

Subvenciones

Subvención educativa

Ponerse en contacto

Contáctenos

Nombre de usuario/Email

Contraseña

Mantenerme conectado

Iniciar sesión

Olvidé mi contraseña ? Todavía no tiene una cuenta? Inscríbase ahora

Mantenerme conectado

academy.Do_not_have_an_account_yet Inscríbase ahora

World Congress 2020 Programa

S135

PBSerum Medical Symposium - PBSerum biotechnological enzymes, at the forefront of non-invasive therapies for tissue regeneration and volume remodelling

Las presentaciones

World Congress 2020
Programa